Table 2
Individual patient outcomes after 2-stage revision for infected TEA.
Sex | Age | F/U (mo) | Underlying disease | Disease period (mo) | Complication | 2nd revision | Time to 2nd revision (mo) | Final VAS | Final ROM | Final MEPS | |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | F | 59 | 57 | HTN, HBV | 20 | Aseptic loosening | One staged (APC) | 41 | 3 | 80 | 75 |
2 | F | 65 | 39 | DM, HTN | 9 | Aseptic loosening | One staged | 18 | 5 | 85 | 65 |
3 | F | 79 | 108 | DM, HTN, Osteoporosis | 6 | Periprosthetic fracture | One staged (APC) | 89 | 2 | 100 | 75 |
4 | M | 83 | 74 | Cancer, HTN,DM | 9 | Infection | 2-staged (APC) | 60 | 5 | 85 | 65 |
5 | F | 82 | 41 | Cancer, HBV HTN,DM | 7 | Infection | 2-staged | 18 | 3 | 85 | 75 |
6 | F | 73 | 24 | HTN, DM, Osteoporosis | 9 | Infection | 2-staged (APC) | 9 | 3 | 80 | 75 |
7 | M | 69 | 24 | DM, Cancer | 6 | – | – | – | 3 | 80 | 85 |
8 | F | 78 | 52 | TB,DM | 5 | – | – | – | 3 | 90 | 85 |
9 | M | 34 | 96 | DM, Osteoposis | 5 | Aseptic loosening | One staged | 24 | 3 | 95 | 80 |
10 | F | 69 | 105 | DM, HTN, Osteoposis | 8 | Infection | One staged (resection) | 37 | 3 | – | 75 |
Mo, months; Disease period, interval time from first visit with the symptom to discharge for 2-stage surgery; HTN, hypertension; HBV, hepatitis type B; DM, diabetes mellitus; TB, tuberculosis; APC, allograft-prosthesis composite graft; Resection, resection arthroplasty.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.